TR199802462T2 - 10,11-Dihidro-10-okso-5H-dibenz/ b, F/azepin-5-karboksamidin yeni türevleri. - Google Patents

10,11-Dihidro-10-okso-5H-dibenz/ b, F/azepin-5-karboksamidin yeni türevleri.

Info

Publication number
TR199802462T2
TR199802462T2 TR1998/02462T TR9802462T TR199802462T2 TR 199802462 T2 TR199802462 T2 TR 199802462T2 TR 1998/02462 T TR1998/02462 T TR 1998/02462T TR 9802462 T TR9802462 T TR 9802462T TR 199802462 T2 TR199802462 T2 TR 199802462T2
Authority
TR
Turkey
Prior art keywords
formula
compounds
trevleri
carboksamidin
okso
Prior art date
Application number
TR1998/02462T
Other languages
English (en)
Inventor
Benes Jan
Manuel Vieira Araujo Soares Da Silva Patricio
Alexander Learmonth David
Original Assignee
Portela & Ca., S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Portela & Ca., S.A. filed Critical Portela & Ca., S.A.
Publication of TR199802462T2 publication Critical patent/TR199802462T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/30—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

(I) genel formülünün bilesikleri, özellikle, merkezi ve periferal sinir sisteminin bazi rahatsizliklarinin iyilestirilmesinde degerli farmasötik özelliklere sahiptir. Bilesikler, farmasötik açidan kabul edilebilir bir tasiyici madde ile farmasötik bilesimler halinde formüle edilebilecektir. Bilesikler, (II) formülü bilesiginin, (III) H2NOR2 formülünün hidroksilamini ya da bir türevi ile ya da (IV) H2NNR3R5 formülünün bir semikarbazid ya da tiosemikarbazid ya da hidrazin türevi ile reaksiyona sokulmasiyla, ya da R' nin OH oldugu (1) formülü bilesiginin,ACOR1 (VI) formülünün ya da CICOOR1 (VII) formülünün bir asilleyici maddesi ile reaksiyonu ile yapilabilmektedir.
TR1998/02462T 1996-05-27 1997-05-27 10,11-Dihidro-10-okso-5H-dibenz/ b, F/azepin-5-karboksamidin yeni türevleri. TR199802462T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT101876A PT101876B (pt) 1996-05-27 1996-05-27 Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida

Publications (1)

Publication Number Publication Date
TR199802462T2 true TR199802462T2 (tr) 2000-07-21

Family

ID=20085604

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02462T TR199802462T2 (tr) 1996-05-27 1997-05-27 10,11-Dihidro-10-okso-5H-dibenz/ b, F/azepin-5-karboksamidin yeni türevleri.

Country Status (19)

Country Link
US (1) US5866566A (tr)
EP (1) EP0810216B1 (tr)
JP (1) JP3592892B2 (tr)
CN (1) CN1101382C (tr)
AR (1) AR007291A1 (tr)
AT (1) ATE199901T1 (tr)
AU (1) AU713807B2 (tr)
BR (1) BR9703403B1 (tr)
CA (1) CA2206172C (tr)
DE (1) DE69704297T2 (tr)
DK (1) DK0810216T3 (tr)
ES (1) ES2156319T3 (tr)
GR (1) GR3035910T3 (tr)
PL (1) PL189298B1 (tr)
PT (1) PT101876B (tr)
RU (1) RU2187503C2 (tr)
SI (1) SI0810216T1 (tr)
TR (1) TR199802462T2 (tr)
WO (1) WO1997045416A1 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004203644B2 (en) * 1999-12-20 2008-04-17 Novartis Ag Pharmaceutical compositions
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0111566D0 (en) * 2001-05-11 2001-07-04 Portela & Ca Sa Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide
GB0112812D0 (en) * 2001-05-25 2001-07-18 Portela & Ca Sa Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
GB2401605A (en) * 2003-05-12 2004-11-17 Portela & Ca Sa Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof
GB2416167A (en) * 2004-07-13 2006-01-18 Portela & Ca Sa Chiral inversion and esterification of (S)- and (R)-10-hydroxy-dibenzazepine carboxamides
GB2422149A (en) * 2005-01-14 2006-07-19 Portela & Ca Sa Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US5173486A (en) * 1991-08-26 1992-12-22 Bristol-Myers Squibb Company Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
EP0810216A1 (en) 1997-12-03
CA2206172C (en) 2002-07-16
RU2187503C2 (ru) 2002-08-20
DK0810216T3 (da) 2001-07-23
AU2974097A (en) 1998-01-05
PT101876B (pt) 1999-09-30
GR3035910T3 (en) 2001-08-31
JP3592892B2 (ja) 2004-11-24
DE69704297D1 (de) 2001-04-26
MX9703846A (es) 1998-06-30
PT101876A (pt) 1997-12-31
PL330141A1 (en) 1999-04-26
AU713807B2 (en) 1999-12-09
BR9703403B1 (pt) 2010-06-29
SI0810216T1 (tr) 2001-08-31
EP0810216B1 (en) 2001-03-21
US5866566A (en) 1999-02-02
CA2206172A1 (en) 1997-11-27
JPH1081669A (ja) 1998-03-31
PL189298B1 (pl) 2005-07-29
ATE199901T1 (de) 2001-04-15
WO1997045416A1 (en) 1997-12-04
ES2156319T3 (es) 2001-06-16
CN1101382C (zh) 2003-02-12
AR007291A1 (es) 1999-10-27
DE69704297T2 (de) 2001-09-20
CN1226234A (zh) 1999-08-18
BR9703403A (pt) 1998-09-15

Similar Documents

Publication Publication Date Title
AU6576898A (en) Fungicidal trifluorophenyl-triazolopyrimidines
TR200102026T2 (tr) Dopamin-D3-reseptör afinitesine sahip triazol bileşikleri.
ZA976705B (en) Process for the synthesis of protected esters of (S)-3,4-dihydroxybutric acid.
AU647490B2 (en) Process for the enantioselective preparation of phenylisoserin derivatives
AU1535595A (en) Watersoluble azole antifungals
AU5932300A (en) Synthesis of zsm-5 and zsm-11
ATE225205T1 (de) Dispergiermittel
EP0714900A3 (de) Alkylhydrogenchlorsilane, Verfahren zu deren Herstellung und deren Verwendung
EP0490816A3 (en) Fluoro-compounds
CA2249663A1 (en) New spirocyclic compounds
AU2102400A (en) Naphthalenehydrazamimides and perylenehydrazamimides
TR200200347T2 (tr) 1,4-İkameli 4,4-diaril sikloheksanlar.
DK0477141T3 (tr)
NZ501694A (en) Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
IL136739A (en) Diol compounds and processes for their preparation
DE69819695D1 (en) Benzimidazolderivate
AU2971997A (en) Intermediates for oligonucleotide synthesis
KR830006237A (ko) 카바모일옥시아미노-1,4-벤조디아제핀의 제조방법
AR007291A1 (es) Nuevos derivados de 10,11-dihidro-10-oxo-5h-dibenz/b, f/azepina-5-carboxamida, metodo de preparacion y su uso en la preparacion de una composicion farmaceutica
KR930700491A (ko) 이속사졸릴이미다졸 유도체, 그의 제조방법 및 약제로서의 그의 용도
TR199801949T2 (tr) Astimi tedavi edici ve bagisiklik bastirici maddeler olarak yeni spesifik immünofilin ligandlar.
TR199901474T2 (tr) Imisazol türevleri için proses.
TR199901484T2 (tr) 2-Amino-2-imidazolin, guanidin ve 2-amino-3,4,5,6-tetrahidropirimidin türevleri hazirlama islemi.
ES8609250A1 (es) Un procedimiento para la preparacion de nuevos derivados de ftalimida.
Gadjeva et al. Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the dopa-oxidase activity of tyrosinase